Form 8-K, current report
Apimeds Pharmaceuticals US, Inc., 8-K filed 2026-08-06
Published 6 Aug 2026 · retrieved 7 Aug 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
8-K filed with the Securities and Exchange Commission by Apimeds Pharmaceuticals US, Inc. (CIK 0001894525) on 2026-08-06.
¶2
Accession number 0001213900-26-086244. EDGAR reports the filing package as 191 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1894525/000121390026086244/0001213900-26-086244-index.htm.